These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 563329)

  • 1. Derivation of hybrids between a thymoma line and spleen cells activated in a mixed leukocyte reaction.
    Köhler G; Lefkovits I; Elliott B; Coutinho A
    Eur J Immunol; 1977 Nov; 7(11):758-61. PubMed ID: 563329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell hybrids. II. BH2 line-derivation by fusion between two (BW5147 X EL-4R) thymoma lines.
    Bubeník J; Perlmann P; Jónsdóttir I; Kypĕnová H; Bubeníková D; Indrová M; Loudová M
    Neoplasma; 1982; 29(1):3-7. PubMed ID: 6978467
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological activity of a T hybrid line. I. Production of an H-2-related suppressor factor with specificity for sheep red blood cells.
    Taussig MJ; Corvalán JR; Binns RM; Roser B; Holliman A
    Eur J Immunol; 1979 Oct; 9(10):768-76. PubMed ID: 93051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of specific antibody-producing tissue culture and tumor lines by cell fusion.
    Köhler G; Milstein C
    Eur J Immunol; 1976 Jul; 6(7):511-9. PubMed ID: 825377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
    Toffaletti DL; Darrow TL; Scott DW
    J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of Fc receptors in hybrid cell lines obtained by fusing mouse splenic macrophages with mouse myeloma cells.
    Sethi KK; Rahmann A; Brandis H
    Eur J Cell Biol; 1979 Aug; 19(3):216-21. PubMed ID: 226369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and binding activity of monoclonal anti-Thy-1 antibodies: evidence for different expression of the two alleles.
    Abehsira O; Edwards A; Simpson E
    Eur J Immunol; 1981 Apr; 11(4):275-81. PubMed ID: 6788568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
    Ting CC; Hargrove ME; Yun YS
    J Immunol; 1988 Aug; 141(3):741-8. PubMed ID: 3260909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybridization between T and B lymphoma cell lines.
    Taussig MJ; Holliman A; Wright LJ
    Immunology; 1980 Jan; 39(1):57-60. PubMed ID: 6966604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of specificity for viral and H-2 antigens by anomalous T killer cells generated in murine leukocyte cultures.
    Shain B; Holt CA; Lilly F
    J Immunol; 1982 Aug; 129(2):722-9. PubMed ID: 6177779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocyte tissue culture lines produced by cell hybridization.
    Hämmerling GJ
    Eur J Immunol; 1977 Oct; 7(10):743-6. PubMed ID: 304002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The subclass specificity for the binding of murine myeloma proteins to macrophage and lymphocyte cell lines and to normal spleen cells.
    Segal DM; Titus JA
    J Immunol; 1978 Apr; 120(4):1395-403. PubMed ID: 641354
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production and characterization of cytotoxic Thy-1 antibody-secreting hybrid cell lines. Detection of T cell subsets.
    Lake P; Clark EA; Khorshidi M; Sunshine GH
    Eur J Immunol; 1979 Nov; 9(11):875-86. PubMed ID: 393521
    [No Abstract]   [Full Text] [Related]  

  • 17. Low density of Thy 1 antigen on mouse effector cells mediating natural cytotoxicity against tumor cells.
    Herberman RB; Nunn ME; Holden HT
    J Immunol; 1978 Jul; 121(1):304-9. PubMed ID: 307576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of tumor-specific cytotoxic effector cells with a novel CD3-/Thy-1+ phenotype.
    Sabapathy TK; Cheng Q; Hui KM
    Cell Immunol; 1995 Nov; 166(1):141-53. PubMed ID: 7585974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo study of pluripotency in intraspecific hybrid cells obtained by fusion of murine embryonic stem cells with splenocytes.
    Matveeva NM; Shilov AG; Kaftanovskaya EM; Maximovsky LP; Zhelezova AI; Golubitsa AN; Bayborodin SI; Fokina MM; Serov OL
    Mol Reprod Dev; 1998 Jun; 50(2):128-38. PubMed ID: 9590528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell hybrids. III. Low tumorigenicity of hybrid cells derived from fusion of high tumorigenic (BW5147 X EL-4R) cell lines.
    Bubeník J; Símová J
    Folia Biol (Praha); 1982; 28(4):274-9. PubMed ID: 6982835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.